
US FDA approves Regeneron’s blood cancer therapy
Over 36,000 new cases of multiple myeloma are estimated to be diagnosed in the U.S. in 2025, according to the American Cancer Society |Image used for representational purpose only | Photo Credit: Getty Images Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood cancer…